MONAS
FINANCIAL
Home
About
Research
Data
Pricing
Team
News
Analysis
Press
Contact
Legal
← News
Guggenheim Maintains Neutral on Amgen, Raises Price Target to $435
Analyst Ratings
AMGN
18h ago
AI-curated analysis for informational purposes only — not investment advice.
Guggenheim Maintains Neutral on Amgen, Raises Price Target to $435
Read the full story at benzinga.com →